Conference Day One - Wednesday September 10, 2025

8:00 am Check In, Coffee & Light Breakfast

8:45 am Chair’s Opening Remarks

Establishing the State of Play for PAT & Emerging Trends in the Pharma & Biopharma Industry

9:00 am Panel Discussion: Exploring the Major Advancements & Challenges of PAT in Drug Development & Manufacturing to Enhance Collaboration & Innovation

  • Carrie Mason Head, Process Analytical Technology Center of Excellence, Research & Development, Lonza Integrated Biologics, Lonza

Synopsis

  • Highlighting emerging trends and technologies for real-time process control
  • Identifying the industry-wide obstacles professionals working with PAT are facing in 2025
  • Proposing approaches to tackle technical, data management and business challenges

9:30 am Quantitative Cellular PAT Analytics Driving Improvements in Advanced Therapy Process & Production Outcomes

  • Renee Hart President & Chief Business Officer, LumaCyte

Synopsis

  • Label-free analysis of intrinsic biochemical and biophysical properties of cells provides real-time insights into cellular changes occurring throughout a manufacturing process
  • Learn how Laser Force Cytologyâ„¢, a label-free, quantitative precision PAT enables real-time monitoring of CQAs and CPPs delivers insights into complex manufacturing processes through its optical force univariate and multivariate machine learning predictive capabilities

10:00 am Speed Networking

Synopsis

A prime chance to make the most of in-person networking and forge new connections designed to maximize your introduction to numerous new individuals and serve as a catalyst for ongoing discussion during the summit.

10:40 am Morning Break & Refreshments

Exploring Technologies & Techniques to Advance Real-Time Pharma

11:40 am Enabling Faster, More Reliable Drug Production: Implementing PAT for Real-Time Release in API/DP Manufacturing

  • Mario Hellings Scientific Director, Analytical Development, Johnson & Johnson

Synopsis

  • Insights from years of hands-on experience implementing PAT in DP manufacturing
  • Challenges and practical solutions for integrating online measurements into real-time process control for API and DP
  • Real-world applications of PAT for enabling real-time release testing: what’s working and what still needs work

12:10 pm Empowering 5.0 BioSolutions Through Real-Time Process Analytical Technology & Computational Controls, Increasing Efficiency & Quality

Synopsis

  • Outlining the importance of digital infrastructure to not only manage large volumes of data but utilize these in decision-making
  • To identify the gaps in expertise that hinder the effective use of advanced data analytics in CM and propose strategies to close these gaps
  • Exploring how organizations can move towards continuous manufacturing without inhouse chemometric expertise

12:40 pm Lunch & Networking Break

Understanding Data Analytics to Enable Real-Time Quality Monitoring of Drugs & Biologics

2:10 pm Leveraging Advanced Data Trending in Continuous Manufacturing to Accelerate Timelines

  • Fernando Barros Modeling & Process Analytical Technology Manager, Hovione

Synopsis

  • Overview of a trending program developed to monitor and optimize continuous manufacturing (CM) processes
  • Challenges and opportunities of working with high-volume, high-frequency data in CM environments

2:40 pm Leveraging PAT in Collaboration with Model-Based Controls to Achieve Automation & Streamline Processes

Synopsis

  • Integration of PAT tools with control models: Demonstrate how PAT data can feed directly into model-based control strategies (e.g: MPC) for real-time decision making and enhanced process understanding
  • Closed-loop automation for consistency and efficiency: Illustrate the benefits of automated feedback control systems driven by PAT measurements, enabling tighter control of critical quality attributes and reducing variability
  • Scalable frameworks for continuous improvement: Highlight how combining PAT with digital twins or first-principles models supports process optimization, scalability, and compliance with Quality by Design (QbD) principles

3:10 pm Afternoon Break & Refreshments

The Business Cases: Demonstrating the Value of PAT

3:40 pm Case Study: Request for Implementation of PAT Tools & Data Trending to Enhance Process Monitoring

  • Dunie Navarro Senior Scientist, Upstream Process Development, Pfizer

Synopsis

  • Considering project lab development history and value added from PAT during campaigns execution and data monitoring
  • Following the tech transfer timeline from PAT request to its introduction in manufacturing towards daily process monitoring
  • Improvement of traditional batch sampling through PAT and effective discussion during process data monitoring

4:10 pm Case Study: Demonstrating Value of Introducing IPC Testing to Accelerate Production & Release Time of Drug Products

Synopsis

  • Success story of smaller-scale PAT tool implementation, where value was demonstrated with small in-process control introductions
  • Learning how companies considering implementation of PAT can justify the business case through small steps
  • Uncovering the return on investment that was seen by moving away from batch testing to gain support from key stakeholders

4:40 pm Panel Discussion: Navigating Resistance to Innovation in Pharma & Strategies to Secure Stakeholder Buy-In for New Technologies

  • Carrie Mason Head, Process Analytical Technology Center of Excellence, Research & Development, Lonza Integrated Biologics, Lonza

Synopsis

  • Sharing of knowledge on challenges encountered with key decision makers in implementing PAT
  • Crowd-source solutions to align stakeholders and gain buy-in for prioritising PAT in both development and manufacturing

5:10 pm Chair’s Closing Remarks